GIGYF2 mutation in late-onset Parkinson’s disease with cognitive impairment

被引:0
|
作者
Javier Ruiz-Martinez
Catharine E Krebs
Vladimir Makarov
Ana Gorostidi
Jose Félix Martí-Massó
Coro Paisán-Ruiz
机构
[1] Biodonostia Research Institute,Department of Neurology
[2] Neurosciences area,Department of Neurology
[3] Hospital Universitario Donostia,Department of Neurosciences
[4] Movement Disorders Unit,Departments of Psychiatry
[5] Centro de investigación biomédica en Red para enfermedades Neurodegenerativas (CIBERNED),undefined
[6] Carlos III Health Institute,undefined
[7] Icahn School of Medicine at Mount Sinai,undefined
[8] One Gustave L. Levy Place,undefined
[9] Human Oncology and Pathogenesis Program,undefined
[10] Memorial Sloan-Kettering Cancer Center,undefined
[11] University of the Basque Country,undefined
[12] EHU-UPV,undefined
[13] Genetics and Genomic Sciences,undefined
[14] Icahn School of Medicine at Mount Sinai,undefined
[15] One Gustave L. Levy Place,undefined
[16] Friedman Brain and Mindich Child Health and Development Institutes,undefined
[17] Icahn School of Medicine at Mount Sinai,undefined
[18] One Gustave L. Levy Place,undefined
来源
Journal of Human Genetics | 2015年 / 60卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although in the last two decades there has been considerable progress in understanding the genetic basis of Parkinson’s disease (PD), the majority of PD is sporadic and its genetic causes are largely unknown. In an attempt to identify novel genetic causes of PD, whole-exome sequencing and subsequent analyses were performed in a family featuring late-onset PD with cognitive impairment. A novel genetic variant (p.Arg610Gly) in the GIGYF2 gene, previously known to be associated with PD, was identified as potential disease-causing mutation. The GIGYF2 p.Arg610Gly mutation situated in the GYF domain of the encoding protein was predicted to be pathogenic and to disrupt the GYF’s ligand-binding abilities. Although further research is still required, this finding may shed light on the GIGYF2-associated mechanisms that lead to PD and suggests insulin dysregulation as a disease-specific mechanism for both PD and cognitive dysfunction.
引用
收藏
页码:637 / 640
页数:3
相关论文
共 50 条
  • [1] GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairment
    Ruiz-Martinez, Javier
    Krebs, Catharine E.
    Makarov, Vladimir
    Gorostidi, Ana
    Marti-Masso, Jose Felix
    Paisan-Ruiz, Coro
    JOURNAL OF HUMAN GENETICS, 2015, 60 (10) : 637 - 640
  • [2] A Novel Mutation in the GIGYF2 Gene in a Patient with Parkinson's Disease
    Necpal, J.
    Vodicka, R.
    Kanovsky, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2017, 80 (06) : 719 - 721
  • [3] Genetic analysis of GIGYF2 in Parkinson's disease
    Prakash, K. M.
    Lim, H. Q.
    Lee, R.
    Pavanni, R.
    Tan, L.
    Tan, E-K
    MOVEMENT DISORDERS, 2009, 24 : S149 - S149
  • [4] Mutation screening of GIGYF2 gene in familial and sporadic Parkinson's disease
    Samaranch, L.
    Lorenzo, E.
    Riverol, M.
    Laquin, R.
    Rodriquez-Oroz, M. C.
    Obeso, J. A.
    Pastor, P.
    MOVEMENT DISORDERS, 2009, 24 : S150 - S151
  • [5] Non synonymous GIGYF2 variants in Parkinson's disease
    Prakash, K. M.
    Lim, H. Q.
    Lee, R.
    Pavanni, R.
    Tan, L.
    Tan, E. K.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S158 - S158
  • [6] Variation in GIGYF2 is not associated with Parkinson disease
    Nichols, W. C.
    Kissell, D. K.
    Pankratz, N.
    Pauciulo, M. W.
    Elsaesser, V. E.
    Clark, K. A.
    Halter, C. A.
    Rudolph, A.
    Wojcieszek, J.
    Pfeiffer, R. F.
    Foroud, T.
    NEUROLOGY, 2009, 72 (22) : 1886 - 1892
  • [7] GIGYF2 Variants Are Not Associated with Parkinson's Disease in Italy
    Bonetti, Monica
    Ferraris, Alessandro
    Petracca, Martina
    Bentivoglio, Anna Rita
    Dallapiccola, Bruno
    Valente, Enza Maria
    MOVEMENT DISORDERS, 2009, 24 (12) : 1867 - 1868
  • [8] GIGYF2 mutations are not a frequent cause of familial Parkinson's disease
    Di Fonzo, Alessio
    Fabrizio, Edito
    Thomas, Astrid
    Fincati, Emiliana
    Marconi, Roberto
    Tinazzi, Michele
    Breedveld, Guido J.
    Simons, Erik J.
    Chien, Hsin F.
    Ferreira, Joaquim J.
    Horstink, Martin W.
    Abbruzzese, Giovanni
    Borroni, Barbara
    Cossu, Giovanni
    Dalla Libera, Alessio
    Fabbrini, Giovanni
    Guidi, Marco
    De Mari, Michele
    Lopiano, Leonardo
    Martignoni, Emilia
    Marini, Paolo
    Onofrj, Marco
    Padovani, Alessandro
    Stocchi, Fabrizio
    Toni, Vincenzo
    Sampaio, Cristina
    Barbosa, Egberto R.
    Meco, Giuseppe
    Oostra, Ben A.
    Bonifati, Vincenzo
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (09) : 703 - 705
  • [9] No evidence for pathogenic role of GIGYF2 mutation in Parkinson disease in Japanese patients
    Li, Lin
    Funayama, Manabu
    Tomiyama, Hiroyuki
    Li, Yuanzhe
    Yoshino, Hiroyo
    Sasaki, Ryogen
    Kokubo, Yasumasa
    Kuzuhara, Shigeki
    Mizuno, Yoshikuni
    Hattori, Nobutaka
    NEUROSCIENCE LETTERS, 2010, 479 (03) : 245 - 248
  • [10] The contribution of GIGYF2 to Parkinson’s disease: a meta-analysis
    Yuan Zhang
    Qi-ying Sun
    Ren-he Yu
    Ji-feng Guo
    Bei-sha Tang
    Xin-xiang Yan
    Neurological Sciences, 2015, 36 : 2073 - 2079